Syndax Pharmaceuticals(DE:1T3)
€8.55+0.01 (+0.07%)
DE:1T3
Syndax Pharmaceuticals earnings date
€8.55
At close:+0.01 (+0.07%)
Syndax Pharmaceuticals (1T3) Q2 2022 Earnings Report
4 Followers
DE:1T3 Q2 2022 EPS Results
- Actual EPS
- -EUR 0.56
- Consensus EPS
- -EUR 0.57
- Beat/Miss
- Beat by +EUR 0.02
- One Year Ago EPS
- -EUR 0.39
DE:1T3 Q2 2022 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 1.23M
- Beat/Miss
- Missed by -EUR 1.23M
- YoY Revenue Growth
- -100.00%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/08/2022
- Time
- After Close
- Conference Call
- Monday, August 8, 2022
DE:1T3 Upcoming Earnings
Syndax Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1T3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.47- | -0.7 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.45-0.49 | -0.63 | 21.43% (+0.13) | |
| Aug 04, 2026 | 2026 (Q2) | -0.40-0.49 | -0.74 | 33.73% (+0.25) | |
| Apr 30, 2026 | 2026 (Q1) | -0.55-0.43 | -0.88 | 51.02% (+0.45) | |
| Feb 26, 2026 | 2025 (Q4) | -0.52-0.70 | -0.99 | 29.09% (+0.29) | |
| Nov 03, 2025 | 2025 (Q3) | -0.65-0.63 | -0.88 | 28.57% (+0.25) | |
| Aug 04, 2025 | 2025 (Q2) | -0.91-0.74 | -0.72 | -3.75% (-0.03) | |
| May 05, 2025 | 2025 (Q1) | -1.12-0.88 | -0.76 | -15.29% (-0.12) | |
| Mar 03, 2025 | 2024 (Q4) | -0.75-0.99 | -0.9 | -10.00% (-0.09) | |
| Nov 05, 2024 | 2024 (Q3) | -0.96-0.88 | -0.65 | -34.25% (-0.22) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

